2016 2019 Clinical Trials History 
NORML
OCTOBER 21, 2019
The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. In June of this year, one applicant – the Scottsdale Research Institute – filed a petition in the US Court of Appeals to order the DEA to comply with its 2016 policy.
The Cannigma
MAY 19, 2021
However, the country has a history of cannabis art dating back millenia , and scholars believe that the plant was used for centuries as a textile and for use in traditional Shinto ceremonies. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. But in modern times?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 21, 2019
Although the DEA refuses to remove marijuana from the schedule 1 list, the Farm Bill is considered to be the most important victory in the history of U.S. In 2016, Tennessee legalized the use of CBD containing no more than 0.9% This does not however, mean that all CBD products are now legal.
Cannabis Law Report
APRIL 8, 2022
This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history.
Cannabis Law Report
JULY 9, 2021
Denver, Colorado was the first jurisdiction to decriminalize the use of psilocybin via ballot initiative in May 2019. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.
Cannabis Law Report
DECEMBER 14, 2019
Medical cannabis was legalized in Australia in 2016 when the Narcotic Drugs Act was amended, allowing cannabis to be grown for medical and scientific purposes. According to Australian marijuana research firm FreshLeaf Analytics, during Q3 of 2019, 76 new products were introduced in the market, up from 54 in Q1.
Cannabis Law Report
JUNE 30, 2019
Lou Correa (D-CA) that would require the VA to conduct clinical trials on the therapeutic potential of cannabis in the treatment of such service-related conditions as post-traumatic stress disorder and chronic pain. The panel also took up a bill sponsored by Rep.
Expert insights. Personalized for you.
104 
Let's personalize your content